Non-platinum combination of gemcitabine in NSCLC
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/17/suppl_5/v82/476958/mdj957.pdf
Reference30 articles.
1. Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non-small cell lung cancer;Hotta;J Clin Oncol,2004
2. Gemcitabine plus best supportive care (BSC) vs. BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome. UK NSCLC Gemcitabine GroupNon-Small Cell Lung Cancer;Anderson;Br J Cancer,2000
3. Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer;Ranson;J Natl Cancer Inst,2000
4. A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC);Roszkowski;Lung Cancer,2000
5. Effect of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer;J Natl Cancer Inst,1999
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, Synthesis, and Anti-Cancer Evaluation of Novel Cyclic Phosphate Prodrug of Gemcitabine;Journal of Medicinal Chemistry;2023-03-03
2. Production of drug-releasing biodegradable microporous scaffold impregnated with gemcitabine using a CO2 foaming process;Journal of CO2 Utilization;2020-10
3. A Pharmacokinetic and Pharmacodynamic Evaluation of the Anti-Hepatocellular Carcinoma Compound 4-N-Carbobenzoxy-gemcitabine (Cbz-dFdC);Molecules;2020-05-08
4. Simultaneous determination of gemcitabine prodrug, gemcitabine and its major metabolite 2′, 2′-difluorodeoxyuridine in rat plasma by UFLC-MS/MS;Journal of Chromatography B;2018-05
5. Discovery of a novel chimeric ubenimex–gemcitabine with potent oral antitumor activity;Bioorganic & Medicinal Chemistry;2016-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3